Findings

What do systematic reviews say?

88 questions · 90 findings · 13 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 11 · 12.2%GRADE not reported 4 · 4.4%Very low 27 · 30%Low 32 · 35.6%Moderate 14 · 15.6%High 2 · 2.2%

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (desloratadine 10 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (desloratadine 20 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Levocetirizine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (levocetirizine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Low

Levocetirizine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (levocetirizine 10 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Low

Longer‐term vs shorter‐term duration of use of topical corticosteroid

Clinician‐reported signs of eczema · people with eczema

1 finding from 1 review

Strategies for using topical corticosteroids in children and adults with eczema 2022 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Longer‐term vs shorter‐term duration of use of topical corticosteroid

Patient‐reported symptoms of eczema · people with eczema

1 finding from 1 review

Strategies for using topical corticosteroids in children and adults with eczema 2022 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Longer‐term vs shorter‐term duration of use of topical corticosteroid

Adverse effects: local · people with eczema

1 finding from 1 review

Strategies for using topical corticosteroids in children and adults with eczema 2022 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Longer‐term vs shorter‐term duration of use of topical corticosteroid

Systemic adverse events at · people with eczema

1 finding from 1 review

Strategies for using topical corticosteroids in children and adults with eczema 2022 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported